Browsing by Author "Gómez-Revuelta, Marcos"
Now showing items 1-7 of 7
-
Article
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
(Oxford University Press, 2020)Background: Different effectiveness profiles among antipsychotics may be a key point to optimize treatment in patients ...
-
Article
Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis
(Oxford University Press, 2022-05-31)Objective Aripiprazole and risperidone are 2 of the most used second-generation antipsychotics (SGAs) worldwide. Previous ...
-
Article
Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial
(Oxford University Press, 2022-07-27)Background Antipsychotic choice for the acute phase of a first episode of psychosis (FEP) is of the utmost importance ...
-
Article
Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program
(Elsevier, 2020)This article describes data related to the research study entitled "Duration of active psychosis during early phases of ...
-
Article
Pattern of long-term weight and metabolic changes after a first episode of psychosis Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort
(Cambridge University Press, 2022-08-16)Background People with psychosis are at higher risk of cardiovascular events, partly explained by a higher predisposition ...
-
Article
Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort
(Elsevier Science BV, 2022)Background: Few investigations have been carried out on metabolic syndrome in antipsychotic- naïve patients with ...
-
Article
Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort
(CAMBRIDGE UNIV. PRESS, 2021)Background: Patients with a first episode of psychosis (FEP) are at higher risk of gaining weight and presenting ...